VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $67,215,020 | -49.4% | 7,173,428 | +32.4% | 0.00% | -42.9% |
Q2 2023 | $132,923,262 | +6.1% | 5,418,804 | +0.6% | 0.01% | 0.0% |
Q1 2023 | $125,289,304 | -54.8% | 5,384,163 | -50.8% | 0.01% | -12.5% |
Q4 2022 | $277,218,254 | +146.6% | 10,952,914 | +87.9% | 0.01% | +14.3% |
Q3 2022 | $112,410,000 | -20.0% | 5,830,417 | +5.6% | 0.01% | -12.5% |
Q2 2022 | $140,572,000 | +30.3% | 5,519,138 | +31.6% | 0.01% | +60.0% |
Q1 2022 | $107,864,000 | +1.9% | 4,193,764 | +65.9% | 0.01% | 0.0% |
Q4 2021 | $105,852,000 | +6.3% | 2,528,107 | +10.5% | 0.01% | 0.0% |
Q3 2021 | $99,568,000 | -2.1% | 2,287,866 | +6.3% | 0.01% | 0.0% |
Q2 2021 | $101,743,000 | +5.6% | 2,151,935 | +14.5% | 0.01% | -16.7% |
Q1 2021 | $96,322,000 | +22.5% | 1,878,727 | -36.0% | 0.01% | +20.0% |
Q4 2020 | $78,618,000 | +146.6% | 2,935,704 | +216.1% | 0.01% | +150.0% |
Q3 2020 | $31,887,000 | -6.8% | 928,830 | +11.2% | 0.00% | 0.0% |
Q2 2020 | $34,224,000 | +690.2% | 835,344 | +561.0% | 0.00% | – |
Q1 2020 | $4,331,000 | +744.2% | 126,378 | +210.1% | 0.00% | – |
Q4 2019 | $513,000 | – | 40,760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
Capital International Investors | 983,300 | $12,365,000 | 0.00% |
Blackstone Inc. | 35,000 | $440,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |